Eight Sleep reached a $1.5 billion valuation in 2026 on the strength of an AI model trained on over a billion hours of sleep data, and has filed with the FDA for Class II clearance to detect sleep apnea.
Noom has expanded AI photo, voice, and text food logging in 2026 as rivals like MyFitnessPal (via its Cal AI acquisition) push into the same space, even as benchmark testing shows AI food recognition still misidentifies about 1 in 4 meals.
Apple shipped a redesigned Health app and better sleep tracking in watchOS 27 at WWDC 2026 but delayed its AI health coach, Project Mulberry, saying it wants more reliable sensor data first.
Samsung's June 2026 Samsung Health update introduces Vitals, Heart Health Score, Daily Cardio Load, and Fitness Index, analyzing five overnight bio-signals ahead of a new Galaxy Watch unveiled July 22.
Oura's Ring 5, shipping June 4, 2026, is 40 percent smaller and adds AI-driven Health Radar blood-pressure monitoring, GLP-1 Insights, and AI meal-tracking features starting at $399.
Whoop's May 2026 update adds AI features called My Memory and Proactive Check-Ins, plus on-demand clinician video consultations and electronic health record syncing for members.
A new study presented at the 2026 International Stroke Conference found Viz.ai's platform cut door-in-door-out transfer time for large vessel occlusion stroke patients by 44% at a regional Adventist Health + Rideout hospital, reducing care-team notification time from 45 minutes to 7.
Cellens, a Boston cancer diagnostics startup, raised a $6.5M Series Seed round led by SOSV for its AI and atomic-force-microscopy-based BioFeel test, which identified every recurrence case in a nearly 100-patient study versus 60-65% sensitivity for standard molecular assays.
Helsinki-based Aiforia secured €20 million in milestone-gated venture debt financing from the European Investment Bank to expand its deep-learning platform for AI-assisted cancer detection in digital pathology.
Owkin announced on June 5, 2026 a multi-year expansion of its Sanofi partnership, licensing its K Pro 'AI Scientist' platform for five years to build autonomous AI agents that independently carry out pharmaceutical research tasks.